Skip to content

Clinical study on acupuncture treatment of knee osteoarthritis based on thermal sensitive acupoint projection positioning technology

Clinical study on acupuncture treatment of knee osteoarthritis based on thermal sensitive acupoint projection positioning technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000019
Enrollment
Unknown
Registered
2025-01-06
Start date
2025-01-07
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Thermal sensitization-based acupoint selection group:Electroacupuncture with thermal sensitization-based acupoint selection
Conventional acupoint selection group:Electroacupuncture with conventional acupoint selection

Sponsors

The Third Affiliated Hospital of Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) aged 45-75 any gender; (2) meet the American College of Rheumatology diagnostic criteria of knee osteoarthritis; (3) report knee pain for more than 3 months; (4) had radiological examination within 6 months indicating ? or ? in Kellgren–Lawrence grade; (5) Score 40mm or greater in visual analogue scale about walking on flat ground for the past week; (6) Willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) History of knee joint surgery or waiting for knee joint surgery (knee replacement or knee arthroscopy surgery); (2) knee pain due to other pathologies (e.g. meniscus tear rheumatoid arthritis joint cavity infection malignancy gout lumbosacral diseases with symptom of lower extremity etc.); (3) arthroscopy history within 1 year or intraarticular injection history within 6 months for the evaluating knee; (4) either knee having received acupuncture/exercise therapy in the last 6 months; (5) severe acute or chronic organic or neuropsychiatric disorder; (6) disorders of coagulopathy (e.g. hemophilia); (7) pacemakers or epilepsy; (8) pregnancy preparation pregnant or lactation period; (9) participated in other clinical studies within the past 1 month.

Design outcomes

Primary

MeasureTime frame
Feasibility;

Secondary

MeasureTime frame
Skin temperature;WOMAC function;Credibility/expectancy questionnaire;Visual analogue scale;

Countries

China

Contacts

Public ContactBaohong Mi

The Third Affiliated Hospital of Beijing University of Chinese Medicine

mibaohong@bucm.edu.cn17703359107

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026